4th Quarter - Termination

AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$200,677
Expense method
C: businesses, Internal Revenue Code section 162(e)
Terminated
Dec 7, 2012

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Termination (this page) Jan 17, 2013 $200,677 Replaced
4th Quarter - Amendment Apr 15, 2013 $200,677 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012

LobbyistCovered position, as disclosed
JASON DUBOIS Vice President, Government Affairs
JO ANNE GLISSON Senior Vice President
JENNIFER BULLARD MADSEN Vice President, Policy and Medical Affairs
SCOTT VAN BUREN MCGOOHAN Director, Regulatory and Reimbursement Affairs
ALAN MERTZ President
FRANCESCA FIERRO O'REILLY Vice President, Government Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Office of Management & Budget (OMB); SENATE; President of the U.S.; HOUSE OF REPRESENTATIVES

Bills named: H.R. 8 (112th), H.R. 3207 (112th), S. 3391 (112th), H.R. 6118 (112th)

Medicare/Medicaid MMM

Health reform law implementation issues including application of the medical device tax to clinical laboratories; in office ancillary services exemption to the Stark law; H.R. 3207, the Modernizing Laboratory Test Standards Act for Patients Act; H.R. 6118/S. 3391, the Taking Essential Steps for Testing Act; the coding, pricing, and placement of molecular pathology laboratory tests; Medicare Clinical Laboratory Fee Schedule reimbursement levels; H.R. 8, the American Taxpayer Relief Act of 2012

LobbyistCovered position, as disclosed
JASON DUBOIS Vice President, Government Affairs
JO ANNE GLISSON Senior Vice President
JENNIFER BULLARD MADSEN Vice President, Policy and Medical Affairs
SCOTT VAN BUREN MCGOOHAN Director, Regulatory and Reimbursement Affairs
ALAN MERTZ President
FRANCESCA FIERRO O'REILLY Vice President, Government Affairs

Contacted: SENATE; HOUSE OF REPRESENTATIVES; President of the U.S.; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Office of Management & Budget (OMB)

Bills named: H.R. 6118 (112th), H.R. 8 (112th), S. 3391 (112th), H.R. 3207 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.